Novartis
Novartis is a healthcare and pharmaceutical company based in Basel, Switzerland, incorporated in 1996.
2
Funding Rounds
$106.5m
Money raised
Overview
Novartis is a healthcare and pharmaceutical company based in Basel, Switzerland, incorporated in 1996.
-
Websites:
- Business model: B2B B2C
- Headquarters: Basel
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo*** Re** | - | - | - |
| An vo* Pl**** | - | - | - |
| Ch** Pa | - | - | - |
| Wi T. Wi | - | - | - |
| Da**** Ho | - | - | - |
| Br** He**** | - | - | |
| An* de Pr* Go | - | - | - |
| Pa Bu** | - | - | |
| To* Bu* | - | - | - |
| Si*** Mo | - | - | |
| Na*** An | - | - | |
| El** Do | - | - | |
| Fr*** va* Ho**** | - | - | - |
| Ch Sa | - | - |
Funding
Funding series
Funding Series Analysis
The company Novartis has raised a total of $106.5m in funding over 2 rounds.
Key Insights:
- DTx Pharma Series B round, March 2021: $100m
- Novartis Grant (money), February 2018: $6.5m
DTx Pharma Series B round, March 2021
$100m
Novartis Grant (money), February 2018
$6.5m
Industries
Novartis is active in the following industries:
- Amyotrophic lateral sclerosis
- Pharmaceutical industry
- Enzyme kinetics
- Pharmacokinetics
- Biopharmaceutical
- Tissue engineering
- Cell therapy
- Genome editing
- Genomics
- Regenerative medicine
- Healthcare
- Biology
- Biotechnology
- Synthetic biology
- CAR T-Cell therapy
- Technology
- Drug delivery
- Drug discovery
- Engineering
- Medicine
- Nanotechnology
- Stem cell technology
- Multiple myeloma
- Medical diagnostics
- Immunotherapy
- Biomedical engineering
- Chemical industry
- Lewy body
- Chemistry
Subsidiaries
Novartis operates through the following subsidiaries:
